Pharmaceutical company to pay $1 million to settle claims on switching drugs

Share this article:

The Maine subsidiary of Omnicare Pharmacy, a Fortune 500 company, agreed to pay $1 million to settle claims that it switched nursing home patients' prescriptions to a medication that would be more profitable for the company.

Omnicare provides medication for about 7,000 nursing home patients in Maine. The company is accused of creating fake prescriptions to switch patients' heartburn medicine, which meant that the state's Medicaid program paid $82 per month per patient instead of $15.

Patients were switched from tablet form of ranitidine, a generic heartburn medication, to the capsule form. Experts say the two different forms are not therapeutically equivalent.

The company denies the claims but said it settled the charges to avoid extraneous litigation costs.

Share this article:

More in News

Also in the news for August 22, 2014

Iowa's nursing homes lost, on average, 41% of their employees each year from 2010-2012 ... Researchers identify proteins necessary in wound healing ... More than 40% percent of SSDI recipients take opioid pain relievers, study says.

CMS: Many skilled nursing providers have poor Medicare certification and recertification practices

CMS: Many skilled nursing providers have poor Medicare ...

The rate of improper Medicare payments to skilled nursing facilities has increased largely due to issues with certification and recertification statements, according to a recently released government memorandum. The Centers ...

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.